NCT01235234View on ClinicalTrials.gov

Trial of CF101 to Treat Patients With Dry Eye Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions
Keratoconjunctivitis Sicca
Interventions
DRUG

CF101

orally q12h

Trial Locations (1)

31048

Bnei Zion Medical Center, Haifa

Sponsors

Lead Sponsor

Can-Fite BioPharma
All Listed Sponsors
lead

Can-Fite BioPharma

INDUSTRY